Status:
UNKNOWN
Confinement and Spondyloarthritis Treatment
Lead Sponsor:
Centre Hospitalier Universitaire de Nice
Conditions:
Spondyloarthritis
Eligibility:
All Genders
18-85 years
Brief Summary
Evaluate the impact of confinement on treatment use in spondyloarthritis. Study hypothesis that with the confinement, subjects will stop their treatment. The main objective is to study the impact of c...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- spondyloarthritis,
- age over 18 ans
- treatment by NSAID or biological treatment to be part of the patient association "ACS" (action contre les spondylarthropathies).
Exclusion
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 15 2020
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04355923
Start Date
April 20 2020
End Date
May 15 2020
Last Update
May 13 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nice
Nice, France, 06300